Schedule 13G ownership disclosure
ADMA Biologics Inc
Common Stock · CUSIP: 000899104
Event date: 2025-03-31
- Filing-level shares
- 12,866,904.00
- Percent of class
- 5.4%
- Invesco Ltd.
Shares: 12,866,904.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-25-000192
- Form type
- SCHEDULE 13G
- Filer
- ADMA BIOLOGICS, INC.
- CIK
- CIK 1368514
- Filed
- May 09, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership